The western blot results showed that the protein level of BAX was up-regulated and that the protein level of Bcl-2 (an anti-apoptotic factor) was reduced by WZ-3146 treatment in glioma cell lines (U251 and LN229) (Fig. 6B). Here, BCL2 is linked to central nervous system cancer.